Display date (DD/MM/YYYY) 13/03/2012
- Market Segments
- Product Categories
Raw Material and Ingredients
Acne vulgaris is a common, chronic and recurring disease that involves multiple etiological factors including follicular hyperkeratinization, increased sebum production, Propionibacterium acne proliferation and inflammation. Taking this into consideration, Sytheon has now designed Synactin™ AC by affecting all four major targets governing acne therapy.
Acne induced pigmenta tion results from Post Inflammatory Hyperpigmentation (PIH). Synactin™ AC also targets hyperpigmentation, thereby broadening its scope to ethnic skin